The Pain Relieving Drug Market - Entering a Crucial Period

Saturday, May 29, 2010 Drug News J E 4
Global Pain Relieving Drug Market Analysis 2010-2025 where will opportunities lie in this diverse market with high growing demand worldwide? In 2009 the global pain relieving drug market generated revenues over $50bn. From 2010 that sector will benefit from new drugs and reformulations of existing products. Cases of pain from many conditions are increasing rapidly. Worldwide the treatment of pain is a priority for healthcare providers with high demand for drugs. Where is the pain relieving drug market heading - technologically and commercially - from 2010 onwards? ( ) Our new report - Global Pain Relieving Drug Market Analysis 2010-2025 - explains how this market will develop and where the opportunities will lie. We show how you can benefit from its developments and potential. There remains unmet therapeutic needs in the treatment of pain. Many conditions have no pain relievers designed for relieving their symptoms or very few. Side effects and safety constitute a challenge for drug developers. There is also increasing demand for pain treatments in developing countries. Novel compounds that show improved safety – with high efficacy – can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2025 our new report explains how you can benefit from this opportunity. Global Pain Relieving Drug Market 2010-2025 covers the following therapeutic categories: * Narcotics for pain * NSAIDs for pain * Treatments for arthritic pain * Treatments for migraine * Treatments for neuropathic pain * Local anaesthetics. What types of therapeutic agents are likely to enter the market from 2010 onwards and will they dominate? Where do the main opportunities lie and what are the drivers and restraints in this market? This report will provide you with the information that you need to understand current trends and future directions in the global pain drug market. To know more and to buy a copy of your report feel free to visit : Related Reports : Neuropathic Pain - Drug Pipeline Analysis and Market Forecasts to 2015 Forecast Insight: Neuropathic Pain - Brighter future for pipeline drugs while current brands downgraded Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Follow us on twitter:


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
CrystalGenomics Announces a Merger with BexPharm a...
Cysview(TM) (Hexaminolevulinate HCL) Approved by t...